Dendritic Cell-Based Treatment Plus Immunotherapy for the Treatment of Metastatic or Unresectable Triple Negative Breast Cancer

NCT05539365 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Study never activated.

Conditions

Anatomic Stage III Breast Cancer AJCC v8
Anatomic Stage IV Breast Cancer AJCC v8
Metastatic Triple-Negative Breast Carcinoma
Unresectable Triple-Negative Breast Carcinoma

Interventions

BIOLOGICAL: Alpha-type-1 Polarized Dendritic Cells
PROCEDURE: Biopsy
PROCEDURE: Computed Tomography
PROCEDURE: Leukapheresis
BIOLOGICAL: Pembrolizumab
OTHER: Quality-of-Life Assessment

Sponsor

Roswell Park Cancer Institute